Using defined regions of the immunoglobulin heavy-chain enhancer linked to minimal promoters and cDNAs that encode the two helix-loop-helix transcription factors ITF-1 and TFE3, we demonstrate that activity of an otherwise repressed enhancer can be stimulated in nonlymphoid cells. Repression in non-B cells is mediated by the |JLE5 motif. Derepression occurs at two levels. First, overexpression of ITF-1, an E12/E47-telated protein that binds the |xE5 motif, leads to transcriptional activation itself. Second, binding of ITF-1 physically displaces a repressor that normally blocks the stimulatory activity of TFE3, which binds the neighboring |xE3 motif. TFE3 can only stimulate enhancer activity in the presence of ITF-1 or in the absence of a |xE5 motif. Hence, one component of the enhancer's cell type specificity can be artificially modulated through a "genetic switch" in which activity is dictated by the relative levels of ITF-1 and a competing repressor.
Activity of the immunoglobulin heavy chain (IgH) enhancer is limited to cells of the lymphoid lineage, primarily B cells. The approximate 250 bp that make up the enhancer have been shown to bind at least eight distinct proteins (for review, see Atchison 1988) . The binding motifs are referred to as E, |xEl, fjiES (equivalent to KE2), |xE2, |xE3, JJLB, |XE4, and octamer (the latter refers to the conserved octanucleotide ATTTGCAT), and mutations introduced into these sites generally reduce enhancer activity (Lenardo et al. 1987; Kiledjian et al. 1988; PerezMetul et al. 1988; Tsao et al. 1988; Libermann et al. 1990; Nelsen et al. 1990 ). The mechanisms that govern the B-cell specificity of the enhancer are not fully understood, although evidence to date suggests that it is determined by both positive and negative control. Support for positive control stems from the identification of Bcell-specific proteins that bind to the octamer motif (Oct-2; Ko et al. 1988; Muller et al. 1988; Scheidereit et al. 1988) and to a site adjacent to JJLE3 (NF-|XB; Araki et al. 1988; Libermann et al. 1990; Nelsen et al. 1990 ). Other proteins shown to bind the enhancer in vitro appear to be present in many cell types. Evidence for negative control comes from the identification of deletions that result in significant, albeit low, levels of enhancer activity in nonlymphoid cells Wasylyk and Wasylyk 1986; Imler et al. 1987; Weinberger et al. 1988 ). Negative regulation is also indicated by experiments with B X T hybrid cells within which IgH en-'This work resulted from an equal contribution by the first two authors. ^Present address: Plant Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037 USA.
hancer activity is actively extinguished (Yu et al. 1989) . Taken together, the evidence suggests that multiple, independent mechanisms may confer both positive and negative regulation.
A specific need for negative control might be inferred by the recent analyses of immunoglobulin transcription factor cDNAs. Two distinct genes encode proteins that bind both the |JLE5 and KE2 motifs (Murre et al. 1989a; Henthorn et al. 1990a) , and at least two additional genes encode distinct (xES-binding (Beckmann et al. 1990 ) and E-binding (Roman et al. 1990) proteins. For the case of the [xE5/KE2-binding proteins, three forms (ITF-1, EI2, and E47) arise from a single gene through alternate splicing or promoter utilization. At least one of these, denoted ITF-I (identical to E47 except for its first coding exon; Henthorn et al. 1990b; Kamps et al. 1990; Nourse et al. 1990 ), functions as a positive-acting transcription factor in transfection experiments of both mammalian cells and yeast (Henthorn et al. 1990a ). The |xE3-binding protein, TFE3, also functions as a positive-acting transcription factor. Interestingly, an E-binding protein, denoted Ig/EBPI, has been shown to form heterodimers with the transcription factor C/EBP (CAAT enhancerbinding protein). All of the genes that encode these particular enhancer-binding proteins are transcribed in both B and non-B cells. Hence, a negative regulatory mechanism would ensure that the action of these apparently ubiquitous positive-acting factors be limited to B cells.
We show here that the one component of the IgH enhancer's overall B-cell specificity is indeed due to negative control. The site that mediates this control is capable of repressing the otherwise ubiquitous activity of a nearby site. Derepression and, consequently, enhancer activation in non-B cells can be achieved by overexpressing the positive-acting transcription factor, ITF-1, which apparently competes with a repressor for overlapping DNA sites.
Results

The iiES motif represses activity of the /uE3 motif in nonlymphoid cells
Previous experiments have shown that enhancer deletions that remove nucleotides near the |JLE2 motif can result in low-level enhancer activity in non-B cells Wasylyk and Wasylyk 1986; Weinberger et al. 1988) . To assess more simply the relative contributions of individual protein-binding motifs within this region, we adopted the approach of examining the behavior of small oligonucleotides (oligos) that carry only one or two known motifs, either individually or in combination. We have studied the behavior of two such oligos that carry either the |xE3 motif alone or the \JLE5 and |xE2 motifs together (Fig. 1 ). The two oligos were designed to carry either normal or mutant motifs and, when linked together, to preserve the normal motif spacing found in the enhancer. Each oligo, either singly or as multiple tandem copies, was placed upstream of a minimal LBK alkaline phosphatase promoter containing only a TATA box (Kiledjian and Kadesch 1990) linked to the bacterial cat gene (expressing chloramphenicol acetyltransferase, CATasc; Gorman et al. 1982 ). The resulting plasmids were then transfected into either B cells (P3-X63Ag8) or non-B cells (NIH-3T3), and CATasc activity was determined. As shown in Figure 2 (top, row A), a single |xE3 oligo was not capable of activating transcription from the TATAbox promoter. However, four tandem copies of the |JLE3 oligo did activate transcription and, when compared to reporter plasmids containing the SV40 enhancer (data not shown), did so with roughly equal efficiency in both B cells and non-B cells (row C). This activity was due specifically to the (xE3 motif because activity was not seen with four tandem copies of an oligo carrying a mutant |xE3 motif (row D). The oligo carrying both the |JLE5 and |JLE2 motifs (|ULE5 -I-|JLE2), even when polymerized to six tandem copies, was unable to activate transcription efficiently from the minimal promoter in either B or non-B cells (row E). However, when polymerized to 12 tandem copies, low levels of activation were obtained in B cells (data not shown). We conclude from these experiments that the |xE3 motif is capable of binding transcription factors from both B cells and non-B cells, whereas the JJLES + |xE2 oligonucleotide, although capable of binding factors, can stimulate transcription only weakly in B cells.
A very different pattern of expression was observed when the two oligos were first linked together and then polymerized to four tandem copies (Fig. 2) . First, although we were unable to detect activity of four copies of the |xE5 -I-|xE2 oligo on its own, when linked to the jxE3 oligo and polymerized to four tandem copies it stimulated activity (on average twofold) in B cells and drastically suppressed activity in non-B cells (row G). By employing a series of mutant |xE5 + |JLE2 oligos (see Fig.  1 ), we established that its stimulatory effect in lymphoid cells was due both to the |xE5 and \xEl motifs (rows H-1). However, the suppression of non-B-cell activity was due primarily to the fxE5 motif because mutations in the |xE5 motif uniquely restored activity of the [xE3 oligo in non-B cells (rows H and ] ]. The threefold difference in CATase levels observed with duplicate transfections of plasmid C into NIH-3T3 cells (Fig. 2) is not representative of the normal experimental variation in this experiment or in those that follow. Relative values obtained from any given transfection were generally found to be reproducible (see Materials and methods).
Our data demonstrate that the IgH enhancer's B-cellrestricted activity can be recapitulated with simply the |JLE5 and |xE3 protein-binding motifs. The results are consistent with a model in which the |xE3 motif binds a ubiquitous transcription factor. However, in non-B cells, its activity is repressed by the |JLE5 motif, which presumably binds a repressor protein. In B cells the repression is absent and both the |JLE5 and )JLE3 motifs stimulate transcription.
Derepression of cell type specificity through the action of a positive-acting transcription factor
Rationale
The |xE5 and |JLE3 motifs are known to bind positive-acting transcription factors. Recently, several Ml so III 64
• 2 --"^i 11 cDNAs have been isolated that encode |JLE5-(and KE2)-binding proteins (E12, E47, ITF-1, and ITF-2; Murre et al. 1989a; Henthom et al. 1990a ) and at least one cDNA that encodes a JJLES-binding protein (TFE3; Beckmann et al. 1990) . Although all of these cDNAs were isolated from B-cell-derived libraries, all of the corresponding mRNAs are detectable in multiple cell types. All are helix-loop-helix proteins. At least one of the |xE5-binding proteins, ITF-1, and the |JLE3-binding protein, TFE3, are positive-acting transcription factors (Beckmann et al. 1990; Henthorn et al. 1990a ). Therefore, it was not surprising to us that the |xE3 oligonucleotide stimulated transcription in both B and non-B cells. However, the presence of ITF-1 (E12/E47) RNA in non-B cells suggested at least two explanations for why the JJLES motif did not stimulate transcription in non-B cells. First, functional ITF-1 protein may not be produced in non-B cells due to either a translational block or a posttranslational modification. Second, ITF-1 protein may be present, but its binding to the |JLE5 motif may be precluded by the presence of the repressor protein whose existence we have postulated here. In this latter case, repression or activation may be established by the relative ratios of the repressor and ITF-1.
To examine further the nature of [xE5-mediated repression in non-B cells, we transfected NIH-3T3 cells with various reporter plasmids along with additional plasmids that express either TFE3 or ITF-1 (Beckmann et al. 1990; Henthorn et al. 1990a) . It was reasoned that these experiments would allow us to examine the effects of elevated levels of TFE3 and/or ITF-1 on the repression phenotype.
The first set of three reporter plasmids and the accompanying results of transfecting NIH-3T3 cells are shown in Figure 3 . Two of the reporters are equivalent to those described in Figure 2 (rows G and H) and carry either a normal or mutant |JLE5 motif (with the accompanying |xE2 motif intact) linked to the |xE3 motif. The third reporter carries a KE2 motif linked to the |JLE3 motif. The KE2 motif shares seven contiguous base pairs with the |xE5 motif, and both motifs are known to bind the ITF-1, EI2, and E47 proteins (the KE2 and |JLE5 motifs are present in opposite orientations). The first lane with each reporter represents results of transfections using 10 [jLg of reporter plasmid DNA alone (lanes 1, 6, and II). These data confirm the results shown in Figure 2 and further illustrate that the KE2 motif also represses |xE3-mediated activity in non-B cells. The remainder of the lanes for each reporter represent experiments in which only 1 |xg of reporter plasmid DNA was transfected. When I | jLg of any of the reporter plasmids was transfected alone, CATase activity for each case fell below our level of detection (lanes 2, 7, and 12).
When the TFE3 expression plasmid was included in the transfections, CATase activity was obtained, but only in conjunction with the reporter carrying the mutated |xE5 element (lanes 3, 8, and 13). Hence, both the |JLE5 and KE2 motifs are individually capable of repressing |xE3-mediated activity, even in the presence of elevated levels of TFE3 protein.
A very different result was obtained when a plasmid expressing ITF-1 was included in the transfections (Fig.  3, lanes 4, 9, and 14) . Transcriptional activation was obtained primarily through the fxE5 motif (poor activation was obtained with the reporter carrying a mutant fjiES site), and to a lesser extent, the fjLE2 site (activation was abolished with a (JLE5, |JLE2 double mutant; data not shown). Activation was also mediated through the KE2 motif. Hence, in the presence of elevated levels of ITF-I, the |xE5, |JLE2, and KE2 motifs support transcriptional activation in non-B cells. Activation by ITF-1 alone did not depend on, nor was it influenced by, the presence of the |xE3 site (M. Kiledjian and T. Kadesch, unpubl.) .
When both plasmids expressing the ITF-I and TFE3 were included in the transfections (Fig. 3, and 15), the levels of CATase obtained were greater than the sum expected from the ITF-1 and TFE3 expression plasmids alone. Using the reporter with intact |xE5 and |JLE3 elements, a combination of TFE3 plus ITF-1 stimulated transcription approximately twofold more than ITF-1 alone. This synergistic effect was more readily apparent with the reporter carrying the linked KE2 and |xE3 motifs. Detectable stimulation of CATase activity by TFE3 was seen only in the presence of ITF-1. This result argues that the repressive effects of the |xE5 motif on the |xE3 site are diminished or perhaps abolished in the presence of excess ITF-1 protein.
Stimulation of IgH enhancer activity in non-B cells
We have shown that the IgH enhancer's B-cell specificity can be simply recapitulated with the two motifs |xE5 and |JLE3. Although our results to this point provide compelling evidence concerning the nature of that specificity, we sought to confirm our results with larger segments of the enhancer. We reasoned that the activities of the |JiE5 and |JLE3 motifs and their responses to ITF-1 and TFE3 should be assessed within the motifs' normal enhancer context. Therefore, we employed reporter plasmids that carry intact or mutated enhancers, present as single or multiple tandem copies, placed 3' of a transcription unit consisting of the human p-globin promoter linked to the cat gene (Kiledjian et al. 1988) . Hence, these reporter plasmids also allow us to measure the effects of ITF-1 and TFE3 on enhancer activity per se, namely, on transcriptional activation at a distance.
The first two enhancer fragments tested and the corresponding transfection results are shown in Figure 4A . Both enhancers (fragment 18, from Kiledjian et al. 1988) extend from the Xbal site (position 1) to the third enhancer core element (position 474; numbering of Gillies et al. 1983 ) and therefore lack the [xE4 and octamer motifs. Although both carry an intact |xE3 motif, one carries a deletion between the |JLE1 and |xE2 motifs and, hence, is also missing the |JLE5 motif. Both were tested as 12 tandem copies.
The results obtained upon transfecting these reporter plasmids into NIH-3T3 cells alone or in combination with plasmids that express TFE3 and/or ITF-1 confirm the results obtained with the minimal promoters (see Fig. 3 ). First, if the | ULE5 motif is deleted, the enhancer becomes active in non-B cells (Fig. 4A, cf. lanes 1 and 6) . Second, under conditions where activity of the reporters alone is not detected (1 ixg of transfected plasmid DNA as opposed to 10 ixg; lanes 2 and 7), transfections of plasmids bearing the TFE3 cDNA activate the enhancer only in the absence of the |JLE5 motif (lanes 3 and 8) . Third, transfecting a plasmid that expresses the ITF-1 cDNA leads to enhancer activation and this requires the |xE5 motif (and to a lesser degree the |JLE2 site). Fourth, activity derived from ITF-1 plus TFE3 is greater than the sum of their individual stimulatory activities. It was confirmed that in this latter context stimulation by TFE3 required an intact | ULE3 site (data not shown).
We also tested the effects of TFE3 and ITF-1 overexpression on the activity of a fully intact IgH enhancer (Fig. 4B) . The enhancer used for these experiments (fragment 2, from Kiledjian et al. 1988 ) extends from a Hinil site (position 345) to an EcoRl site (position 683) and thus includes all the major motifs known to be important for enhancer activity. When linked to the p-globin cat reporter as 12 tandem copies, it could not be activated in NIH-3T3 cells by overexpressing TFE3 (lane 2), but could be activated by ITF-1 (lane 3). Again, these results are in agreement with those presented with our other reporter plasmids. With a single copy of this enhancer linked to the p-globin cat reporter, ITF-1 alone could not stimulate to a detectable level (lane 7), but ITF-1 in combination with TFE3 could. The profound stimulation of a single enhancer by TFE3 in the presence of ITF-1 (synergy) is reminiscent of the result obtained with the minimal reporter plasmid carrying the KE2 and |JLE3 motifs (Fig. 3) . These effects support the conclusion that the otherwise repressive activity of the fxES motif is diminished in the presence of ITF-1. Hence, it appears that binding of ITF-1 to the |xE5 motif not only activates transcription on its own but also, in a more conventional sense, derepresses the |JLE3 motif.
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To establish further the relevance of our reporter plasmids to a normal immunoglobulin gene, we carried out an additional series of cotransfection experiments using a single copy of the enhancer linked to the VI IgH promoter (Fig. 4C) . The VI IgH promoter has been reported to contain a |JLE3 site (Peterson and Calame 1989) , and consistent with this we found that it alone was weakly stimulated by TFE3 in NIH-3T3 cells (cf. lanes I and 2). ITF-1 was unable to stimulate the promoter alone. However, when the promoter was linked to the IgH enhancer, a combination of ITF-1 and TFE3 was found to stimulate the promoter very well (lane 8). Neither TFE3 nor ITF-1 could effect the stimulation as well (lanes 6 and 7). As expected, both the |JLE3 and |JLE5 sites were required for the activation (data not shown). These results corroborate our previous findings and demonstrate that ITF-1 and TFE3 function synergistically to activate the enhancer and immunoglobulin gene transcription. 
Discussion
Activation of the IgH enhancer in non-B cells
The results presented here demonstrate that B-cell specificity of the IgH enhancer can be recapitulated by the two protein-binding motifs, |xE5 and |xE3. In B cells, both motifs act to stimulate transcription. This is consistent with the recent isolation, from B-cell-derived libraries, of cDNAs that encode |xE5-and |jLE3-binding proteins that function as positive-acting transcription factors (Beckmann et al. 1990; Henthorn et al. 1990a ). In non-B cells an isolated |xE3 motif stimulates transcription, but if it is linked to either a |xE5 or KE2 motif, transcription stimulation is abolished. The repressive activities of the |xE5 and KE2 motifs are maintained even under conditions where transfected cells express highly elevated levels of the jxES-binding transcription factor TFE3. In fact, our estimates suggest that the |xE5 motif is capable of repressing TFE3-mediated activity by > 50-fold. Although we have no direct in vitro physical evidence for a repressor protein binding to the |xE5 motif, our in vivo functional data support the existence of such a protein (or protein complex).
The repressive activities of the |JLE5 and KE2 motifs are not seen in the presence of elevated levels of the |JLE5-binding transcription factor ITF-1. One interpretation is diagramed in Figure 5 and proposes that ITF-I binding physically displaces the repressor. Two arguments support this model. First, the repressor site and the ITF-1-binding site overlap. Mutations of 2 bp within the fxE5 motif (see Fig. 1 ) that reduce the binding of ITF-1 also fail to repress. Moreover, the KE2 motif, which is identical to the |JLE5 motif in seven out of seven contiguous base pairs, also both represses the |JLE3 motif and binds ITF-I. Hence, the repressor element and the ITF-Ibinding site are probably both found within that 7-bp identity. Second, enhancer activation by TFE3 is seen only in the absence of a |xE5 motif or in the presence of elevated levels of ITF-I. One prediction of the model is that mutant forms of ITF-1 that can bind DNA, but cannot activate transcription themselves, should allow activation by TFE3. Our attempts to express these types of mutant ITF-1 proteins in cells have not yet been successful.
Synergistic activation of the enhancer by ITF-I and TFE3 was observed in several of our experiments. This was manifested in two ways. First, with the exception of the VI promoter, we have not observed transcriptional stimulation by TFE3 alone of minimal promoters carrying single |xE3 sites or of single copies of the enhancer. Since TFE3 readily activates promoters carrying multiple |xE3 motifs and activates multiple copies of the enhancer (lacking the |JLE5 site), we conclude that TFE3 is able to function synergistically with itself. The same conclusions hold true for activation by ITF-I alone. Second, the levels of stimulation by ITF-1 plus TFE3 were always higher than the sum of those obtained with either transcription factor alone. Hence, TFE3 is able to function synergistically with ITF-I. The magnitude of these latter effects varied between individual reporter 3T3 Cells Figure 5 . Model for the effect of ITF-1 overexpression on transcriptional activity mediated through the (xE5 and \xE3 enhancer motifs. (R) Proposed repressor protein or repressor complex. Although a repressed phenotype (normal NIH-3T3 cells, top] shows bound TFE3 protein, we have no evidence for such a bound complex and it is shown here only for the sake of illustration. The bottom panel indicates the proposed situation for NIH-3T3 cells that contain elevated levels of ITF-1 in which both ITF-1 and TFE3 are bound and both stimulate transcription (depicted by the large arrow).
constructs and were most apparent with reporters carrying a single copy of the intact enhancer. Although we established the paradigm for negative regulation being a component of the synergy by using multicopy binding sites, we have no compelling reason to suspect that negative regulation is not also occurring with single-copy oligonucleotides or with single-copy enhancers.
Role of a genetic switch in establishing cell type specificity
Our results indicate that we can reverse cell-type-specific control simply by changing the relative concentrations of a positive-acting transcription factor (ITF-1) and a repressor. Hence, using a broad definition, this system constitutes a genetic switch (Ptashne 1986) . Cell type specificity of the IgH enhancer may therefore be a reflection of the relative concentrations of active ITF-1 and the repressor in B cells and non-B cells. Unfortunately, we cannot yet conclude this for certain since we still know very little about the repressor nor do we understand the nature of the native ITF-1 protein. This latter issue is underscored by two points. First, although the E2A gene (which encodes El2, E47, and ITF-1) is transcribed in both B and non-B cells, there is no evidence that non-B cells produce active ITF-1. Second, ITF-I binding itself may be modulated by B-cell-specific proteins (or modifications). This idea stems from the fact that El2 and E47, alternate forms of ITF-1, can interact with a variety of other proteins through their respective helix-loop-helix motifs and that these interactions may influence DNA-binding affinity (Murre et al. 1989a,b) . For example, the heteromers of MyoD and E12 bind to DNA more effectively than either protein alone (Murre et al. 1989b ). Although our results suggest that ITF-1 can function on its own (it can also stimulate transcription efficiently in yeast; Henthorn et al. 1990a) , our experiments have only measured ITF-1 activity under conditions where the protein is overexpressed. It should be emphasized that our results neither support nor contradict the existence in B cells of a MyoD-like protein that, in conjunction with ITF-1, may bind the |JLE5 more efficiently than ITF-1 alone. Perhaps such a heteromeric ITF-1 complex is the normal species that effectively displaces the repressor, which may itself be ubiquitous. An additional level of complexity to this system is underscored by the recent cloning of cDNAs encoding two additional |JLE3-binding proteins, TFEB and USE (Carr and Sharp 1990; Gregor et al. 1990 ). It is not yet known whether these proteins can activate transcription through the IgH enhancer or whether they serve as targets of |ULE5-mediated repression.
There is ample precedent in eukaryotes for positiveand negative-acting factors binding to adjacent or overlapping sites (for review, see Levine and Manley 1989) . In higher eukaryotes, this is best exemplified by the competition among homeo box proteins in Drosophila and by competition among steroid receptor proteins in mammalian cells. In transfection experiments, the Drosophila even-skipped (eve] and engrailed [en] homeo box proteins are potent repressors of the stimulatory activities of both z2 and fushi tarazu homeo box proteins (Jaynes and OTarrell 1988; Han et al. 1989) . Although all of these proteins are able to bind similar DNA sequences, it is not yet clear whether the repressive activity of eve and en are merely a consequence of passive competition for activator-binding sites or a consequence of more interactive inhibitory mechanisms. Several examples of steroid hormone-mediated repression suggest direct binding competition between inactive forms of the steroid hormones and positive-acting factors. Competition between an inactive form of the glucocorticoid receptor (GR) and activated CREB protein has been implicated in the control of the human glycoprotein hormone a-subunit gene (Akerblom et al. 1988; Oro et al. 1988) . Stimulation of a Xenopus vitellogenin gene by estrogen receptor (ER) has been shown to be down-regulated by thyroid hormone receptor (TR) (Glass et al. 1988) . In this case the common ER-and TR-binding site represents a negative-acting TR response element (nTRE). In general, nTREs, in the absence of TR, may otherwise bind positive-acting transcription factors (Damm et al. 1989 ). Although our results play upon these same themes, they are unique in the sense that they involve setting up relatively long-term, lineage-specific transcriptional events in mammalian cells.
Activity of the IgH enhancer is controlled at multiple levels. The Oct-2 protein likely contributes to its overall B-cell-specific activity (although the Oct-2 protein is not alone capable of stimulating activity of an enhancer situated 3' to a transcription unit; Muller et al. 1988) . The octamer motif has also been implicated in the enhancer's extinction in B x T hybrid cells (Yu et al. 1989) . A B-cell-restricted activity has also been attributed to a motif adjacent to the |JLE3 motif, designated |xB (Araki et al. 1988; Libermann et al. 1990; Nelsen et al. 1990 ). Presumably a ixB-binding protein further activates enhancer activity in B cells. Additional motifs other than JJLES and |xE3 are also known to be important for enhancer function. We propose that the genetic switch exemplified by the |xE5 and | ULE3 motifs constitutes only one component of a multilayered mechanism that governs the enhancer's overall B cell specificity.
Materials and methods
Plasmids
Plasmids were constructed using standard techniques (Ausubel et al. 1987) . The reporter plasmids containing oligonucleotides linked to the liver/bone/kidney alkaline phosphatase (LBK AP) promoter TATA box evolved from pSVlAgpt (Kadesch and Berg 1986 ) and pLA44cat(X) (Kiledjian and Kadesch 1990) . The resulting plasmids (detailed map available on request) contained the following order of sites: Bglll, oligo DNA, BamHl, Spel, Xbal, BamHl, LBK AP TATA box, cat gene. Oligo DNA refers to the various oligonucleotides corresponding to enhancer protein-binding motifs (synthesized by the University of Pennsylvania Cancer Center). The BamHl site that normally exists 3' to the cat gene in the parental plasmids was destroyed. Sequential duplications of oligonucleotide sequences upstream of the LBK AP promoter were constructed essentially as described by Kiledjian et al. (1988) . Reporter plasmids carrying enhancer fragments 2 and 18 have been described elsewhere (Kiledjian et al. 1988 ). The plasmids pSVE2-5 and pSV2A-X3, which express the ITF-1 and TFE3 cDNAs, respectively, from the SV40 early promoter, have also been described elsewhere (Beckmann et al. 1990; Henthom et al. 1990a ). The IgH VI promoter (Eaton and Calame, 1987) was isolated as a BamHl fragment and used to replace the (3-globin promoter upstream of the cat gene. The nE5 + |jiE2 and (JLE3 oligonucleotides are diagramed in Figure 1 . The KE2 oligonucleotide was the following (the KE2 motif is underlined):
5'-GATCTCTCCCAGGCAGGTGGCCCAGATTG-3' 3'-AGAGGGTCCGTCCACCGGGTCTAACCTAG-5'
Cell lines and transfections
Cell lines were maintained in Dulbecco's modified Eagle medium (DMEM), high glucose, supplemented with 10% fetal bovine serum, 150 jJig/ml glutamine, 100 U/ml penicillin, and 100 M-g/nil streptomycin. The murine plasmacytoma line P3-X63.Ag8 was transfected with 50 |xg of the various reporter plasmids by calcium phosphate coprecipitation ). The plasmid pSV2Apap (20 | jLg), which expresses placental alkaline phosphatase (PAP; Henthorn et al. 1988) , was included in each experiment to normalize transfection efficiencies. The murine fibroblast line NIH-3T3 was transfected by calcium phosphate coprecipitation (Graham and van der Eb Cold Spring Harbor Laboratory Press on June 24, 2017 -Published by genesdev.cshlp.org Downloaded from 1973) using the amounts of reporter and expression plasmids indicated in addition to 5 jjig of the plasmid pCHllO, which expresses p-galactosidase (Hall et al. 1983) , to normalize transfection efficiencies. Both P3X63.Ag8 and NIH-3T3 cells were harvested 44-48 hr after transfection and assayed first for PAP or p-galactosidase. Normalized amounts of cell extract were then assayed for CATase (Gorman et al. 1982) . Each construct was transfected a minimum of three times.
Evaluation of expeiimental variation
We have noted, perhaps due to the use of up to five separate plasmids in our transfections, that CATase values obtained with a common set of plasmids may vary between experiments. However, relative trends obtained from any single transfection series were found to be reproducible. Hence, we have based our experimental conclusions primarily on qualitative changes imparted by ITF-1 and/or TFE3 overexpression rather than on precise quantitative differences.
